Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 8/20 | 0.58 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | CTSS | P25774 | 5/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 3/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.41 |
| ▸ | MMP12 | P39900 | 1/20 | 0.41 |
| ▸ | KLK7 | P49862 | 1/20 | 0.41 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4997014 | 1.00 | PPARA (0.58) | PPARAPPARGCTSSPTPN1CTSK | |
| SCHEMBL5001099 | 0.90 | PPARA (0.60) | PPARAPPARGCTSSPTPN1CTSK | |
| SCHEMBL5001100 | 0.90 | PPARA (0.60) | PPARAPPARGCTSSPTPN1CTSK | |
| SCHEMBL5007444 | 0.87 | PPARA (0.60) | PPARAPPARGCTSSPTPN1CTSK | |
| SCHEMBL5007442 | 0.87 | PPARA (0.60) | PPARAPPARGCTSSPTPN1CTSK | |
| SCHEMBL7094300 | 0.85 | CTSS (0.53) | PPARAPPARGCTSSPTPN1CTSK | |
| SCHEMBL5041377 | 0.85 | CTSS (0.53) | PPARAPPARGCTSSPTPN1CTSK | |
| SCHEMBL5007491 | 0.85 | PPARA (0.55) | PPARAPPARGCTSSPTPN1CTSK | |
| SCHEMBL5007488 | 0.85 | PPARA (0.55) | PPARAPPARGCTSSPTPN1CTSK | |
| SCHEMBL5007480 | 0.85 | PPARA (0.57) | PPARAPPARGCTSSPTPN1CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7396846-B2 | Growth hormone secretagogues | ELI LILLY AND COMPANY (US) | 2008-07-08 | — | — | US | disclosed |
| EP-1497316-B1 | GROWTH HORMONE SECRETAGOGUES | LILLY CO ELI (US) | 2006-07-05 | — | — | EP | disclosed |
| US-20050240001-A1 | 2-(2-Amino-2-methylpropionylamino)-3-(2,6-difluoro-3-methylphenyl)methoxy propionic acid N-[5-(4-chlorophenyl)-3,3-dimethyl-1,1-dioxo-2,3-dihydroisothiazol-4-ylmethyl]-N-ethylamide; endogenous human growth hormone controller; non-peptidyl in nature, more metabolically stable | ELI LILLY AND COMPANY (US) | 2005-10-27 | — | — | US | disclosed |
| EP-1497316-A2 | GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 2005-01-19 | — | — | EP | disclosed |
| WO-2003087070-A2 | GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 2003-10-23 | — | — | WO | disclosed |